Rapid and Selective Targeting of Heterogeneous Pancreatic Neuroendocrine Tumors
Summary: Design of tissue-specific contrast agents to delineate tumors from background tissues is a major unmet clinical need for ultimate surgical interventions. Bioconjugation of fluorophore(s) to a ligand has been mainly used to target overexpressed receptors on tumors. However, the size of the f...
Main Authors: | G. Kate Park, Jeong Heon Lee, Eduardo Soriano, Myunghwan Choi, Kai Bao, Wataru Katagiri, Do-Yeon Kim, Ji-Hye Paik, Seok-Hyun Yun, John V. Frangioni, Thomas E. Clancy, Satoshi Kashiwagi, Maged Henary, Hak Soo Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | iScience |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004220301905 |
Similar Items
-
Risk Stratification of Pancreatic Neuroendocrine Neoplasms Based on Clinical, Pathological, and Molecular Characteristics
by: Jin Ho Choi, et al.
Published: (2022-12-01) -
Surgical Management of Pancreatic Neuroendocrine Tumors
by: Megan L. Sulciner, et al.
Published: (2023-03-01) -
A recurrence of pancreatic non-functioning neuroendocrine tumor mimicking splenosis
by: Yeon-Ji Kim, et al. -
Physicochemical Descriptors in Biodistribution and Clearance of Contrast Agents
by: Sung Ahn, et al.
Published: (2023-08-01) -
Tumor Heterogenity in Gastro-Entero-Pancreatic Neuroendocrine Neoplasia
by: Ludovica Magi, et al.
Published: (2021-01-01)